RegMed Daily, Mid-Day, 10/24/11, defining the next 2 months’ market, stocks flat line to slow recovery
The 6 W’s: Who, what, where, when, why and what of it … Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
AMEX: CUR receives FDA approval to dose patients in Cervical Region in ongoing ALS Trial Read more…
Receives Singapore Health Sciences Authority (HSA) regulatory clearance to begin P2 trial Read more…
Good morning! Here’s what you … might need to know to start the day… Read more…
End of Day, Cause and Effect … Read more…
Dr Andrew Pecora MD FACP CPE, NeoStem’s Chief Medical Officer has forwarded 3 papers Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
ATHX receives Funding to advance Clinical Development of MultiStem® Read more…
Good morning! Here’s what you … might need to know to start the day… Read more…
End of Day, Cause and Effect … Read more…

Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.